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Abstract
Techniques for small molecule screening are widely used in biological mechanism study and drug discovery. Here, we
reported a novel adipocyte differentiation assay for small molecule selection, based on human mesenchymal stem cells
(hMSCs) transduced with fluorescence reporter gene driven by adipogenic specific promoter - adipocyte Protein 2 (aP2; also
namely Fatty Acid Binding Protein 4, FABP4). During normal adipogenic induction as well as adipogenic inhibition by
Ly294002, we confirmed that the intensity of green fluorescence protein corresponded well to the expression level of aP2
gene. Furthermore, this variation of green fluorescence protein intensity can be read simply through fluorescence
spectrophotometer. By testing another two small molecules in adipogenesis –Troglitazone and CHIR99021, we proved that
this is a simple and sensitive method, which could be applied in adipocyte biology, drug discovery and toxicological study
in the future.
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Introduction
Adipogenesis is a process of adipocyte formation. Adipocytes in
white adipose tissue are crucial for maintaining energy balance
and body homeostasis [1]. White fat can secrete different kinds of
adipokines to regulate many activities, including glucose and lipid
metabolism, inflammatory responses, angiogenesis and reproduc-
tion throughout the body [2]. Dysfunction of this cell population
would lead to many kinds of metabolic diseases, such as
cardiovascular diseases and type 2 diabetes [3,4]. Understanding
the mechanisms involved in adipogenesis might add novel insights
to the adipose tissue development, as well as therapies of metabolic
diseases. To this end, potent and specific small molecule regulators
in adipogenesis might serve as powerful research tools. Research-
ers have made many efforts to screen different kinds of small
molecules to study the molecular mechanisms of adipogenic
differentiation and for drug discovery [5,6,7].
At present, there are many methods utilized in differentiation
assays to screen small molecules, including luciferase reporter
assay, antibody label assay and fluorescence protein assay
[8,9,10,11,12,13]. One study screened 500 compounds from a
small-molecule library for activators and repressors in adipogenesis
by using aP2Luc-3T3F442A reporter cell line [6]. However,
murine cell lines are not ideal models to study human
adipogenesis, due to the genetic profiling differences from human
cells. Human mesenchymal stem cells derived from bone marrow
can differentiate into osteocytes, adipocytes and chondrocytes, and
maintain this multipotency during in vitro culture [14,15].
Moreover, hMSCs-derived adipocytes have been proved to be
morphologically and functionally identical to human mature fat
cells [16]. Therefore, hMSCs are considered as a useful
differentiation model to unravel the molecular events involved in
human adipogenesis. In this study, we introduce a simple and
sensitive system using hMSCs transduced with aP2 promoter
driving hrGFP reporter gene for screening small molecules in
adipogenesis.
Results
Generation of the aP2-hrGFP hMSC reporter cell line
To establish a stem cell-based system for small molecule
screening, we generated the human mesenchymal stem cell line
transduced with aP2-hrGFP lentivector. The expression clones,
pLV/Final-puro-aP2-hrGFP (Fig. 1a) was generated as described
in methods. After virus transduction and antibiotic selection,
purified aP2-hrGFP hMSCs were attained. Observing under the
phase-contrast microscope, there was no significant morphological
difference between the untransduced and transduced hMSCs
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multipotency of hMSCs, we double transduced these cells with two
vectors containing adipocyte specific promoter (aP2) and osteo-
blast specific promoter (2.3Col, collagen type I 2.3 kb) [17]
respectively, and obtained purified aP2-hrGFP/2.3Col-RFP
hMSCs after antibiotics selection, which can be used to screen
compounds for effects on adipogenic and osteogenic lineages
simultaneously. (Fig. S1, a, b)
Characterization of aP2-hrGFP hMSCs
To examine the characteristics of aP2-hrGFP hMSCs, we used
FACS to analyze cell surface markers of hMSCs. Compared with
untransduced hMSCs, transduced cells expressed the same panel
of known markers, including CD29, CD44, CD73, CD166, but
did not express specific markers of hematopoietic stem cells, such
as CD34 and CD45 (Fig. 1d, 1e), which indicated that transduced
cells maintained the phenotype of hMSCs.
Furthermore, to demonstrate the multipotency of aP2-hrGFP
hMSCs, cells were subjected to differentiate into adipo-, osteo-,
and chondrogenic lineages. By oil red O staining, lipid droplets
can be observed in the cytoplasm of adipocytes on Day 15 of
adipogenic differentiation (Fig. 1f). After 15 days of culture in
osteogenic medium, hMSCs differentiated into osteoblasts, which
were confirmed by strong alizarin red S staining (Fig. 1g).
Chondrogenic differentiation was confirmed by immunohisto-
chemical analysis, which showed the presence of human type II
collagen (Fig. 1h).
Verification of aP2 promoter controlled cell-based system
To verify the aP2-hrGFP hMSCs selection system, we first
performed normal adipogenic experiment. In order to determine
the most suitable time point for detection, we performed
adipogenic induction for 30 days. We used real-time PCR and
fluorescence spectrophotometer to analyze the variation of aP2
gene expression and hrGFP intensity among different differenti-
ated time points. The results indicated that both the aP2 gene
expression and hrGFP intensity peaked on D18 of adipogenic
induction, and decreased in later time period (Fig. S2, a, b).
However, D18 differentiated cells showed less cell viability and
had the similar lipid droplet accumulation as D15 differentiated
cells (Fig. S2, c–e). As a result, we believe that it is much more
suitable to detect aP2 gene expression and hrGFP intensity on D15
of differentiation, rather than D18 of differentiation.
Next, during 15 days of adipogenic induction, we observed the
hrGFP gene expression every three days through fluorescence
microscope and performed the oil red O staining for comparison.
Also, we detected the fluorescence intensity by fluorescence
spectrophotometer at the same time points, and together with
detection of aP2 gene expression by real-time PCR. The results
showed that the expression levels of fluorescence protein
concurred with the lipid droplet accumulation (Fig. 2a, 2b). The
fluorescence intensity increased in a time-dependent manner,
corresponding to the elevation of aP2 gene expression (Fig. 2c, 2d).
And then, we performed immunofluorescence staining with anti-
aP2 antibody, which demonstrated that aP2 and hrGFP genes
were co-expressed in adipocytes (Fig. 2e).
To further prove the feasibility of this system, we treated aP2-
hrGFP hMSCs with LY294002 - an inhibitor of Phosphatidylinositol
(PI) 3-kinase (PI3K) pathway [18]. PI3K signaling pathway is involved
in the early stage of adipogenesis. Inhibition of PI3K pathway would
inhibit the mRNA expression of PPAR gamma and LPL, which are
essential genes in the process of adipogenic differentiation [19].
The tests were performed in 1:2 serial dilutions, with 80 mM,
40 mM, 20 mM and 10 mM final concentrations, respectively (with
the same concentration of the solvent DMSO (0.16%) in all
groups) (Fig. 3a). After 15 days of induction, the 96-well test plates
were read through the fluorescence spectrophotometer. Besides,
RNA samples of Day 15 differentiated cells were collected, and we
used real-time PCR for quantitative detection of three adipogenic
specific genes expression – PPAR gamma, aP2 and GPDH. By
comparing the data from the fluorescence spectrophotometer with
that from real-time PCR, we showed that the results of
fluorescence spectrophotometer were in consistent with that of
real-time PCR (Fig. 3b, 3c). This finding demonstrated that the
aP2 gene expression was closely co-related with hrGFP gene
expression from another aspect, and the fluorescence protein assay
was as sensitive as real-time PCR. Additionally, from the data of
fluorescence spectrophotometer, we found that the inhibition
effect of LY294002 acted in a dose-dependent manner, with the
effective concentration for half-maximum response (EC50)o f
15 mM and the maximum effective concentration of 40 mM.
Tests of other small molecules
To find out whether this system can also be applied in detection
of other small molecules, we treated aP2-hrGFP hMSCs with one
agonist and one inhibitor of adipogenesis - Troglitazone and
CHIR99021.
Troglitazone is an agonist for PPAR gamma. It can stimulate
adipogenesis by elevating adipogenic specific genes expression
[20]. The assay was designed in 1:2 serial dilutions, with 10 mM,
5 mM, 2.5 mM, 1.25 mM, 0.625 mM, 0.3125 mM and 0.15625 mM
final concentrations, respectively (with the same concentration of
the solvent DMSO (1%) in all groups). After 15 days of
differentiation, a dose-dependent manner of Troglitazone can be
observed through fluorescence microscope, and reflected from the
data of real-time PCR and fluorescence spectrophotometer
(Fig. 3d–f). From the result of fluorescence spectrophotometer,
the EC50 of Troglitazone was 0.496 mM, and the maximum
effective concentration was 10 mM.
CHIR99021 is a selective inhibitor of glycogen synthase kinase
3 (GSK3), which can mimic stimulation of Wnt signaling pathway
in preadipocytes. CHIR99021 inhibits adipogenesis by blocking
the induction of CCAAT/enhancer-binding protein a (CEBPa)
and PPAR gamma [21]. In this assay, we set up 6 test groups of
CHIR99021 in 1:2 serial dilutions, with 1 mM, 500 nM, 250 nM,
125 nM, 62.5 nM and 31.25 nM final concentrations, respectively
(with the same concentration of the solvent DMSO (0.016%) in all
groups). In this assay, the data from fluorescence spectrophotom-
eter displayed a dose-dependent manner of CHIR99021, with the
EC50 of around 206 nM, and the maximum effective concentra-
tion was 1 mM (Fig. 3g, 3i). Such dose-dependent manner of
CHIR99021 can also be confirmed by real-time PCR analysis of
aP2 gene expression (Fig. 3h).
Figure 1. Vector construction and lentivirus transduction, characterization, and differentiation of hMSCs. a, Construction of pLV/Final-
puro-aP2-hrGFP; b, Phase contrast microscopy of hMSCs at Passage 9, one day before transduction; c, Phase contrast microscopy of hMSCs at Passage
11 after puromycin selection; d, Flow-cytometric analysis of cell surface antigens of untransduced hMSCs; e, Flow-cytometric analysis of cell surface
antigens of transduced hMSCs; f, Oil red O staining of adipogenic differentiated transduced hMSCs; g, Alizarin red S staining of osteogenic
differentiated transduced hMSCs; h, Collagen II staining of chondrogenic differentiated transduced hMSCs. Bar=50 mm.
doi:10.1371/journal.pone.0013014.g001
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In this study, we introduced a hMSC reporter cell line (aP2-
hrGFP hMSCs) as a model applying in small molecules selection in
adipogenesis. Firstly, hMSCs were transduced with a lentivector
containing aP2-hrGFP. After characterizing the phenotypic and
multipotent property of transduced hMSCs, we verified the
efficacy of this system through normal adipogenic induction and
adipogenic inhibition by Ly294002. Finally, we treated the aP2-
hrGFP hMSCs with Troglitazone and CHIR99021 to further
prove the feasibility of this system. After serials of tests, we showed
that this system is an efficient method for small molecules
screening in adipogenesis.
Luciferase reporter assay, antibody label assay and fluorescence
protein assay are frequently used by researchers in screening small
compounds. Compared with the former two methods, fluores-
cence protein assay seems to be an appropriate protocol for high-
throughput differentiation screening. It circumvents the extra time
and money spent during testing, which might be a strength for
high content analysis [22]. Furthermore, this approach provides a
manner of real-time and noninvasive observation for researchers.
Researchers can observe the change of individual cells continu-
ously during the differentiation process and would not need to fix
or fractionate cells [12]. Unlike luciferase reporter assay, which
measures the total amount of luciferase activity in test wells,
fluorescence protein assay reveals data of individual cells in
differentiation assay, where the cell population is not homoge-
neous [23]. Even though the toxic effect on cells of fluorescence
protein raises concern about the application of this method, we did
not observe obvious cell death during our experiments. To address
this issue, we performed cell titer glo assay to test the cell viability
of D0 undifferentiated cells and D15 differentiated cells. The result
showed no significant difference of cell viability between these two
groups. (Fig. S3)
aP2 gene is not only one of the specific markers of mature
adipocytes, but also one of the target genes of PPAR gamma [24].
Since the interrelation between PPAR gamma – a central
regulator of adipogenesis and aP2 gene expression has been well
studied, it is supposed that aP2 promoter-driven reporter gene
assay is a more rapid and sensitive procedure than others to
identify agents in adipogenesis [25]. From our data, the aP2-
driven green fluorescence protein assay is a simple and sensitive
protocol for small molecules selection in adipogenesis. After 15
days of adipogenic induction, we detected the fluorescence
intensity simply through fluorescence spectrophotometer, with
no extra procedures required. More importantly, by comparing
with the results of real-time PCR, we proved that this method is as
sensitive as real-time PCR that can reflect the exact variation of
adipogenic associated genes.
In the future, many improvements can be made in this system to
facilitate high-throughput screening. Multi-well plates could
improve the efficiency of screening. Also, using the Gateway
system, we could change different tissue specific promoters or
other types of fluorescence reporter genes, according to the
research need. Additionally, this system can be applied in other
fields, such as toxicological study. Several research groups have
reported that some environmental compounds or contaminants,
like TCDD or benzo(a)pyrene, may have toxic effects on
adipogenesis in the body through Ah receptor (AhR) [26,27].
But most of these studies used oil red O staining and real-time
PCR as detection tools for analysis, which is either insensitive or
time-consuming. By using this fluorescence protein assay, these
studies can be carried out very efficiently.
All together, this is a pioneer study of applying fluorescence
reporter gene to test small molecules function in adipogenesis,
which might become a powerful screening assay facilitating




hMSCs were obtained from Cyagen Biosciences Inc.(Guangz-
hou, China). The culture medium contained low glucose DMEM
(Hyclone, Logan, Utah, USA) supplemented with 10% fetal
bovine serum (FBS) (Hyclone), 100 IU/ml penicillin (Hyclone),
and 100 mg/ml streptomycin (Hyclone). Medium was changed
every 2–3 days. After reaching confluence, cells were detached by
0.25% trypsin for 1–2 min at 37uC and replated for continuous
passage.
Vector construction, lentivirus production and
transduction
To generate a pDestpuro vector, we used the puromycin
resistance encoding sequence to replace both the blasticidin
resistance encoding sequence and the bacterial EM7 promoter of
lentiviral 2k7bsd vector (kindly provided by Dr. David M. Suter,
University of Geneva Medical School, Geneva, Switzerland) [28].
In order to generate entry vectors, we generated rat aP2 promoter
(3708 bp) flanked with attB sites from BAC clone CH230-359E6
(provided by Children’s Hospital Oakland Research Institute,
Oakland, California, USA) using PCR, subsequently cloned the
promoter PCR product into pDONR
TMP4–P1R (Invitrogen,
Carlsbad, California, USA) by utilizing the Gateway BP
recombination reaction following the product instructions. A
hrGFP gene was cloned into pDONR
TM221 (Invitrogen) by the
same method. The resulting vectors, which we named pUp-aP2
and pDown-hrGFP, were then recombined into the pDestpuro
vector following the protocol for LR recombination reaction using
the Gateway LR plus clonase enzyme mix (Invitrogen) to construct
the expression lentiviral vector, designated as pLV/Final-puro-
aP2-hrGFP.
The lentiviral particles were prepared by transient cotransfec-
tion of 293FT cells with the lentiviral vector pLV/Final-puro-aP2-
hrGFP and ViraPower
TM Lentiviral packaging mix (Invitrogen)
using Lipofectamine 2000 (Invitrogen). Three days after transfec-
tion, viral particles were harvested from the medium, filtered
through 0.45-mm pore-sized polyethersulfone membrane, and
concentrated by ultracentrifugation (50,000 g, for 120 minutes at
4uC).
For lentiviral transduction, hMSCs were washed with PBS and
dissociated to single cells by 0.25% trypsin and were replated with
lentiviral particles and 5 mg/ml polybrene (Sigma, St Louis,
Figure 2. Normal adipogenic induction of aP2-hrGFP hMSCs. a, hrGFP expression of aP2-hrGFP hMSCs in different days of adipogenesis; b, Oil
red O staining results of aP2-hrGFP hMSCs in different days of adipogenic differentiation; c, Normalized mRNA expression of aP2 gene determined by
real-time PCR analysis during adipogenesis; d, Fluorescence intensity detection of aP2-hrGFP hMSCs by fluorescence spectrophotometer during
normal adipogenic induction; Data are presented as mean 6 SD of three independent experiments, and the p-values in the graph show the statistical
significance of the difference between each test day and Day 0. (
wp,0.05;
wwp,0.01). e, Immunofluorescence staining of aP2 protein on Day 15 of
adipogenic induction (e). Bar=50 mm.
doi:10.1371/journal.pone.0013014.g002
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medium after infection for 12 hours. After twice transduction,
puromycin (Sigma) was added to the culture medium at a
concentration of 1–5 mg/ml and maintained for 5 days.
Fluorescence-activated cell sorting analysis
Membrane antigen expression of untransduced and transduced
hMSCs was determined by flow cytometry. Cells were harvested
and incubated with monoclonal antibodies against human
antigens including CD29, CD34, CD44, CD45, CD73, and
CD166 (all from BD Biosciences, Palo Alto, CA, USA). Irrelevant
isotype-identical antibody (BD Biosciences) served as negative
control. Samples were analyzed by collecting 10,000 events using
Cell-QuestH software (BD Biosciences).
Osteogenic and chondrogenic differentiation of
transduced hMSCs
For osteogenic differentiation, transduced hMSCs were seeded
in six-well plate at the density of 5610
3/cm
2. When the cells
reached 80% conflucence, culture medium was replaced with the
osteogenic medium containing 10
27 M dexamethasone (Sigma),
10 mM b-glycerophosphate (Sigma), and 50 mg/ml vitamin C
(Sigma). After 14 days, osteogenic differentiation was evaluated by
alizarin red S staining.
Chondrogenic differentiation was induced on cell pellet culture
system as previously described [29]. In brief, 500,000 transduced
hMSCs were suspended in one 15 ml conical tube with 2 ml
induction medium including DMEM containing 3% FBS, 10 ng/
ml TGF-b3 (PeproTech, NJ, USA), 6.25 mg/mL insulin (Sigma),
6.25 mg/mL transferrin (Gibco), 1.25 mg/mL BSA (Sigma), and
1 mM pyruvate (Sigma), The medium was replaced every 3 days
for 21 days.
Adipogenic differentiation of transduced hMSCs
To induce adipogenic differentiation, one-day post-confluent
transduced hMSCs were cultured in DMEM containing 10%
FBS, 10 mg/ml insulin, 1 mM dexamethasone, 200 nM indometh-
acin (Sigma) and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma).
The medium was replaced every 3 days for 15 days. For
verification assays, transduced hMSCs were seeded in 96-well
plates. On differentiation, LY294002 (Cayman Chemical, Ann.
Arbor, MI, USA) (dissolved in DMSO, storage concentration is
50 mM) or CHIR99021 (Stemgent, Cambridge, MA, USA)
(dissolved in DMSO, storage concentration is 6 mM) was added
in the induction medium, while Troglitazone (Cayman Chemical,
Ann Arbor, MI, USA) (dissolved in DMSO, storage concentration
is 1 mM) was added in the induction medium without indometh-
acin (DMSO as solvent control). During differentiation, we
observed the hrGFP expression through fluorescence microscope
every three days. hrGFP intensity was detected by Fluorescence
Spectrophotometer (Tecan Trading AG, Switzerland) at the
excitation wavelength of 485 nm and emission wavelength of
535 nm. For each molecule, three independent experiments were
performed and there were six replicate wells for each concentra-
tion. Each well was detected for three times and data were
collected symmetrical from four different points in a well.
Immunochemistry and histochemistry
For immunofluorescence studies, differentiated transduced cells
were incubated with primary antibody against aP2 (Abcam,
Cambridge, UK) over night at 4uC. The secondary antibody, goat
Cy3-conjugated anti-mouse (Jackson, West Grove, Pennsylvania,
USA), was added at room temperature for 1 h in the dark.
Nucleus was counterstained with Hoechst33342 (Sigma). Undif-
ferentiated cells were used as negative controls.
For oil red O staining, adipogenic differentiated cells were fixed
and incubated with oil red O (Sigma) for 30 min. For alizarin red
S staining of calcium, osteogenic differentiated cells were fixed and
incubated with alizarin red S (Sigma) for 20 min. For assessment
of chondrogenic differentiation, tissue sections of formalin-fixed
and paraffin-embedded samples were incubated with anti-collagen
II antibody (1:200, Chemicon), overnight at 4uC. After rinsing
with PBS, slides were incubated for 10 min at room temperature
with biotin-conjugated secondary antibodies, followed by incuba-
tion with streptavidin-conjugated peroxidase working solution for
10 min. Subsequently, sections were stained for 15–30 min with 3-
amino-9-ethylcarbazole (AEC), counterstained with Mayer’s
haematoxylin. Negative controls were prepared by substituting
PBS for primary antibody.
Real-time PCR analysis
Total RNA was extracted from undifferentiated and differen-
tiated transduced hMSCs with Trizol reagent (Invitrogen). For
eliminating any contaminating genomic DNA, the total RNA was
subjected to DNase I (Fermentas, Maryland, USA) according to
the directions of the manufacturer. Reverse transcription was
carried out using Murine Leukemia Virus reverse transcriptase
(Fermentas) and oligo-dT primers (Fermentas) according to the
manufacturer’s instruction.
Real-time PCR was performed with the Bio-Rad CFX96 Detection
System (Bio-Rad, Hercules, CA, USA) and QuantiTect SYBR Green
PCR Master Mix (Qiagen, Valencia, CA, USA). All reactions were run
in triplicate. The primers used in this study were as follows: GAPDH
(forward), 59-GAAGGTGAAGGTCGGAGTC-39;G A P D H( r e -
verse), 59-GAAG ATGGTGATGGGATTTC-39; PPAR gamma
(forward), 59-CGAGAAGGAGAAGCTGT TGG-39; PPAR gamma
(reverse), 59-TCAGCGGGAAGGACTTTATGTATG-39;a P 2( f o r -
ward), 59-AGCACCATAACCTTAGATGGGG-39; aP2 (reverse), 59-
CGTGGAAGTGACGCCTTTCA-39.G P D H( f o r w a r d ) ,5 9-AG-
GAAGACATTGGAGGCAAAAA-39;G P D H( r e v e r s e ) ,5 9-GCA-
GCCTGGACCACATCTG-39;
Cell Titer Glo Assay
Undifferentiated and differentiated cells were plated in 96-well
opaque plate (10
5cells/well). Cell Titer Glo assay was performed
Figure 3. Adipogenic differentiation assays of aP2-hrGFP hMSCs with LY294002 (a–c), Troglitazone (d–f) and CHIR99021 (g–i). a,
Fluorescence observation of LY294002 assay with different concentrations, after 15 days of adipogenic induction; b, Normalized mRNA expression of
PPAR gamma, aP2 and GPDH genes determined by real-time PCR in LY294002 assay; c, Fluorescence intensity detection of LY294002 assay on Day 15
of differentiation; d, Fluorescence observation of aP2-hrGFP hMSCs with different concentrations of Troglitazone, on Day 15 of differentiation; e,
Normalized mRNA expression of aP2 gene determined by real-time PCR in Troglitazone assay; f, Fluorescence intensity detection of Troglitazone with
relative concentrations, after 15 days of adipogenic induction; g, Fluorescence observation of aP2-hrGFP hMSCs with different concentrations of
CHIR99021, on Day 15 of differentiation; h, Normalized mRNA expression of aP2 gene determined by real-time PCR in CHIR99021 assay; i,
Fluorescence intensity detection of CHIR99021 with relative concentrations, after 15 days of adipogenic induction. Data are presented as mean 6 SD
of three independent experiments, and the p-values in the graph show the statistical significance of the difference between each test group and the
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Obispo, CA, USA), and measured by Spectrophotometer (Tecan
Trading AG, Switzerland). Data were collected from three
independent experiments.
Statistical analysis
Data are presented as means 6 SDs, and the one-way ANOVA
test was used for testing statistical significance.
Supporting Information
Figure S1 a, Vector construction of pLV/Final-bsd-2.3Col-RFP
by the multisite gateway technology. This 2.3Col promoter was
kindly provided by Professor Peng Liu [Yin D, et al. 2009]. We
used PCR to generate attB-flanked 2.3Col promoter, and
subsequently cloned the promoter PCR product into
pDONRTMP4-P1R (Invitrogen) by Gateway BP recombination
reaction. The RFP gene was cloned into pDONRTM221
(Invitrogen) by the same method. The resulting vectors, named
pUp-2.3Col and pDown-RFP respectively, were then recombined
into the pDestbsd vector by LR recombination reaction to
construct the expression lentiviral vector, designated as pLV/
Final-bsd-2.3Col-RFP; b, Fluorescence protein expression of aP2-
hrGFP/2.3Col-RFP hMSCs in different days of differentiation.
These cells were induced to differentiate with dual lineage
promoting medium consisting of a mixture of adipogenic and
osteogenic medium (V/V; 1/1). Along the 15 days of induction,
the reporter gene expression was observed every three days
through the fluorescence microscope. Bar=50 mm.
Found at: doi:10.1371/journal.pone.0013014.s001 (2.74 MB TIF)
Figure S2 a, Normalized mRNA expression of aP2 gene
determined by real-time PCR during adipogenesis; b, Fluores-
cence intensity detection of aP2-hrGFP hMSCs by fluorescence
spectrophotometer during normal adipogenic induction; c, Cell
Titer Glo assay of D0, D15 and D18 adipogenic differentiated
cells; d and e, Oil red O staining of D15 and D18 differentiated
cells. Data are presented as mean 6 SD of three independent
experiments, and the p-values in the graph show the statistical
significance of the difference between each test day and the D0
control group. (wp,0.05; wwp,0.01); Bar=50 mm.
Found at: doi:10.1371/journal.pone.0013014.s002 (2.35 MB TIF)
Figure S3 Cell Titer Glo assay of D0 and D15 adipogenic
differentiated cells. Data are presented as mean 6 SD of three
independent experiments, and the p-values in the graph show the
statistical significance of the difference between D0 and D15
differentiated cells. (wp,0.05; wwp,0.01).
Found at: doi:10.1371/journal.pone.0013014.s003 (4.10 MB TIF)
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